Congenital Hypopituitarism: Current Agnostic Genetics Faces Its Limits.

J Clin Endocrinol Metab

MIRCen, CEA Paris-Saclay, 92265 Fontenay-aux-Roses Cedex, France.

Published: June 2024

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgae361DOI Listing

Publication Analysis

Top Keywords

congenital hypopituitarism
4
hypopituitarism current
4
current agnostic
4
agnostic genetics
4
genetics faces
4
faces limits
4
congenital
1
current
1
agnostic
1
genetics
1

Similar Publications

An Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management.

J Clin Med

October 2024

Department of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro Majadahonda, Calle Joaquín Rodrigo, 1, 28222 Majadahonda, Madrid, Spain.

Article Synopsis
  • - This article reviews hypopituitarism (HP), a condition where the pituitary gland doesn't produce enough hormones, detailing its causes like tumors, genetic issues, and other factors such as trauma and medications.
  • - Diagnosis involves clinical evaluations and hormonal tests, although these tests can have limitations; identifying specific hormonal deficiencies is critical for treatment.
  • - Hormone replacement therapy is the main treatment for HP, improving patient quality of life, but awareness of potential interactions among therapies is crucial; ongoing research and a multidisciplinary approach are also highlighted for better management of the disorder.
View Article and Find Full Text PDF

Introduction: Congenital hypopituitarism (CH) is characterized by the deficiency of pituitary hormones. Among CH patients, 85% lack a molecular diagnosis. Whole Exome Sequencing (WES) identified a homozygous variant (c.

View Article and Find Full Text PDF

Introduction: Hypogonadotropic hypogonadism (HH) is a treatable cause of nonobstructive azoospermic male infertility. Gonadotropin treatment can successfully induce spermatogenesis in most patients, although comprehensive quantitative summary data on spermatogenic outcomes like those required to induce pregnancy is lacking in the literature.

Materials And Methods: Systematic review and meta-analysis of outcomes related to male reproductive function following gonadotropin treatment.

View Article and Find Full Text PDF

The molecular basis of hypoprolactinaemia.

Rev Endocr Metab Disord

December 2024

Department of Paediatric Endocrinology, Great Ormond Street Children's Hospital, London, UK.

Hypoprolactinaemia is an endocrinopathy which is typically encountered as part of a combined pituitary hormone deficiency picture. The vast majority of genetic causes identified to date have been in the context of congenital hypopituitarism with multiple co-existent endocrinopathies. This is primarily with its closest hormonal relation, namely growth hormone.

View Article and Find Full Text PDF
Article Synopsis
  • - Prolactin deficiency is uncommon and typically results from pituitary disorders such as large tumors and apoplexy, leading to hypopituitarism where prolactin is often the last hormone affected.
  • - This deficiency can arise from various congenital syndromes and acquired conditions, including Sheehan syndrome and immune checkpoint-inhibitor-induced hypophysitis.
  • - In women, low prolactin levels hinder lactation post-childbirth, but recombinant human prolactin has shown effectiveness in stimulating milk production in women with low levels.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!